Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Hasılat
8,494
8,466
8,100
7,502
6,560
6,005
Hasılat Artışı (YoY)
2%
5%
8%
14%
9%
7%
Satınalma Maliyeti
6,805
6,476
5,772
5,509
4,819
4,238
Brüt Kâr
1,689
1,989
2,328
1,993
1,740
1,767
Satış, Genel ve İdari
832
973
1,300
1,085
912
949
Araştırma ve Geliştirme
386
393
419
345
341
298
İşletme Giderleri
1,227
1,452
1,787
1,497
1,271
1,269
Diğer Finansman Gelirleri (Giderleri)
-1
4
2
-2
-2
-6
Kâr Öncesi Gelir
446
533
532
471
421
411
Kira Vergisi Gideri
48
46
26
45
59
64
Net Kâr
382
470
496
411
348
324
Net Income Growth
Kâr Artışı
-15%
-5%
21%
18%
7%
8%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
678.98
691.21
689.6
660.6
627.1
621.9
Hisse Değişimi (Yıllık Üst Üste)
-3%
0%
4%
5%
1%
0%
EPS (Diluted)
0.54
0.68
0.72
0.62
0.56
0.52
EPS Artışı
-15%
-6%
16%
11%
8%
8%
Öz sermaye akışı
268
155
-59
513
9
140
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
19.88%
23.49%
28.74%
26.56%
26.52%
29.42%
Faaliyet Kâr Marjı
5.42%
6.34%
6.66%
6.61%
7.14%
8.29%
Kâr Marjı
4.49%
5.55%
6.12%
5.47%
5.3%
5.39%
Özsermaye Karlılık Oranı
3.15%
1.83%
-0.72%
6.83%
0.13%
2.33%
EBITDA
--
677
631
588
541
552
EBITDA Marjinali
--
7.99%
7.79%
7.83%
8.24%
9.19%
D&A EBITDA için
--
140
91
92
72
54
Faaliyet Kârı
461
537
540
496
469
498
Faaliyet Kâr Marjı
5.42%
6.34%
6.66%
6.61%
7.14%
8.29%
Verilen Vergi Oranı
10.76%
8.63%
4.88%
9.55%
14.01%
15.57%
Follow-Up Questions
Shandong Xinhua Pharmaceutical Company Limited'in temel mali tabloları nelerdir?
SHNXY'ün temel finansal oranları nelerdir?
Shandong Xinhua Pharmaceutical Company Limited'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Shandong Xinhua Pharmaceutical Company Limited kârlı mı?
Shandong Xinhua Pharmaceutical Company Limited'in herhangi bir yükümlülüğü var mı?
Shandong Xinhua Pharmaceutical Company Limited'in tedavüldeki hisse sayısı kaçtır?
Önemli İstatistikler
Önceki Kapanış
$18.19
Açılış fiyatı
$18.19
Günün Aralığı
$18.19 - $18.19
52 haftalık aralık
$18.19 - $18.19
İşlem hacmi
100
Ort.Hacim
0
EPS (TTM)
0.80
Dividend yield
--
Piyasa Değeri
$899.9M
SHANDONG XINHUA PHARMACEUTICAL nedir?
Shandong Xinhua Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zibo, Shandong and currently employs 7,296 full-time employees. Shandong Xinhua Pharmaceutical Co Ltd is a China-based company mainly engaged in the development, manufacturing and sales of chemical raw materials, pharmaceutical preparations and chemical products. The firm operates three segments. The Chemical Raw Materials segment is mainly engaged in the development, manufacturing and sales of raw materials for antipyretics and analgesics such as caffeine series, ibuprofen series, aspirin series, dopamine series, barbiturates and pipemidic acid. The Pharmaceutical Preparations segment is mainly engaged in the development, manufacturing and sales of tablets, injections and capsules such as pipemidic acid tablets, aminopyrine and nimodipine tablets. The Pharmaceutical Intermediates and Other Products segment is mainly engaged in the development, manufacturing and sales of pharmaceutical intermediates and other products. The firm mainly operates its business in the domestic market and overseas markets such as the Americas and Europe.